Longwood-Founded Verastem Oncology Receives FDA Approval of COPIKTRA™ (duvelisib) Capsules September 24, 2018
Verastem Oncology Announces Investigator Sponsored Study on Duvelisib in Combination with Venetoclax September 6, 2018
Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO™ Study in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma September 6, 2017
